Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Predominance of M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Susann RößlerInstitute for Medical Microbiology and Virology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0003-3906-7782
Sébastien BoutinInstitute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.ORCID 0000-0002-0499-2460
Reinhard BernerDepartment of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-6216-9173
Markos K Tomidis ChatzimanouilDepartment of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID 0009-0000-9250-6604
Meriem BelheouaneGerman Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.
Jan RuppInstitute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.
Matthias MerkerGerman Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.ORCID 0000-0003-1386-2331
Dresden GAS Study GroupInstitute for Medical Microbiology and Virology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.
Nicole TöpfnerDepartment of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-9693-4419
Dennis NurjadiInstitute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.ORCID 0000-0002-1278-5939
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
backgroundSeveral European countries have reported a rise in invasive Group A
methodsWe performed whole-genome sequencing (WGS) on 189 invasive
resultsThe most common
conclusionOur findings confirm the pre-pandemic circulation of M1
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023. · full record | OpenQuestion